Lung Cancers Completed Phase 3 Trials for Cediranib (DB04849)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00795340Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment